Consistently, FIBP knockdown significantly decreased xenograft tumor burden (Fig. 2d), as evidenced by reduced tumor weight (Fig. 2e) and tumor size during the observation time of 5 weeks (Fig. 2f) for both SW620 cells and HCT116-CSCs. Here, FIBP is linked to neoplasm.